Clinical Trial Update: ButCoIns - Metabolic Effects of Resistent Starch and Arabinoxylans in Subjects With Metabolic Syndrome [NA]

View source ↗

Summary

The trial evaluating metabolic effects of resistant starch and arabinoxylans in subjects with metabolic syndrome has completed. The snippet provides sponsor and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: Aarhus University Hospital | Conditions: Metabolic Syndrome | NA | Status: COMPLETED